BackgroundCutaneous leishmaniasis is distributed worldwide, including Brazil. Its
several clinical forms need to be distinguished from other dermatoses.
Clinical similarities and lack of a gold standard diagnostic tool make
leishmaniasis-like lesions a challenging diagnosis.Objectives.To report the final diagnosis of patients primarily suspected of having
American tegumentary leishmaniasis (ATL).Methods.A retrospective cross-sectional study was conducted on the basis of medical
records of 437 patients with clinical suspicion of ATL, registered in
electronic hospital system between 1980 and 2013. Demographic, clinical, and
laboratory data were compiled.Results.Analysis of 86 cases (19.7%) registered as ATL in one of the hypothesis
revealed a different final diagnosis; 55 (63.9%) and 31 cases (36.1%) had
skin and mucosal lesions, respectively. In 58 cases (67.4%), the requested
PCR did not identify Leishmania sp. In 28 cases (32.5%),
biopsies established the diagnosis and confirmed tumors, mycobacteriosis,
and subcutaneous or systemic mycosis. Overall, 27% of the cases had
inflammatory etiology, mainly nasal nonspecific inflammatory processes; 27%
had infectious etiology, especially paracoccidioidomycosis and leprosy; 20%
had neoplastic etiology, mainly basal and squamous cell carcinoma; 15% had
miscellaneous etiology, including neuropathic ulcer, traumatic ulcers,
idiopathic ulcer; 11% missed the follow-up.Study limitationsSome cases had no final diagnosis due to loss of follow-up.Conclusion.ATL can be confused with several differential diagnoses, especially
inflammatory and infectious granulomatous diseases as well as non-melanoma
skin cancers. Clinicians working in tropical areas should be aware of the
main differential diagnosis of leishmaniasis-like lesions.